Registration Strip Icon for default 무료로 등록하여 실시간 주식 시세, 대화형 차트, 실시간 옵션 플로우 등을 받아보세요.

DRMA

Dermata Therapeutics (DRMA)

Dermata Therapeutics Inc
일자:
정렬 기준:
 검색 관련기사 보기:NASDAQ:DRMA
일자시간출처헤드라인심볼기업
2024/01/1306:06Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRMADermata Therapeutics Inc
2024/01/0611:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DRMADermata Therapeutics Inc
2024/01/0611:01Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DRMADermata Therapeutics Inc
2024/01/0611:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DRMADermata Therapeutics Inc
2024/01/0611:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DRMADermata Therapeutics Inc
2023/12/1814:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DRMADermata Therapeutics Inc
2023/12/1607:00Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:DRMADermata Therapeutics Inc
2023/12/0907:29Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:DRMADermata Therapeutics Inc
2023/12/0806:05Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:DRMADermata Therapeutics Inc
2023/11/3007:16Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:DRMADermata Therapeutics Inc
2023/11/1006:09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DRMADermata Therapeutics Inc
2023/11/1006:08Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRMADermata Therapeutics Inc
2023/09/1505:32Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DRMADermata Therapeutics Inc
2023/08/1105:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRMADermata Therapeutics Inc
2023/08/1105:16Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DRMADermata Therapeutics Inc
2023/08/0405:31Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DRMADermata Therapeutics Inc
2023/07/2813:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:DRMADermata Therapeutics Inc
2023/07/2805:50Edgar (US Regulatory)Form 424B4 - Prospectus [Rule 424(b)(4)]NASDAQ:DRMADermata Therapeutics Inc
2023/07/1222:02Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:DRMADermata Therapeutics Inc
2023/07/0805:21Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:DRMADermata Therapeutics Inc
2023/06/2405:29Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:DRMADermata Therapeutics Inc
2023/06/2405:19Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:DRMADermata Therapeutics Inc
2023/06/1306:28Edgar (US Regulatory)Small Company Offering and Sale of Securities Without Registration (d)NASDAQ:DRMADermata Therapeutics Inc
2023/05/2506:14Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DRMADermata Therapeutics Inc
2023/05/1205:08Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:DRMADermata Therapeutics Inc
2023/05/1205:08Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DRMADermata Therapeutics Inc
2023/04/0105:11Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:DRMADermata Therapeutics Inc
2023/03/3105:08Edgar (US Regulatory)Amended Statement of Beneficial Ownership (sc 13d/a)NASDAQ:DRMADermata Therapeutics Inc
2023/03/2119:01Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(3) (424b3)NASDAQ:DRMADermata Therapeutics Inc
2023/03/2105:37Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:DRMADermata Therapeutics Inc
 검색 관련기사 보기:NASDAQ:DRMA